{"id":"indeloxazine","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Anticonvulsants","category":"pharmacology"},{"label":"Antidepressive Agents","category":"pharmacology"},{"label":"Central Nervous System Agents","category":"pharmacology"},{"label":"Psychotropic Drugs","category":"pharmacology"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"(+/-)-indeloxazine","offLabel":[],"synonyms":["indeloxazine hydrochloride","indeloxazine","(+/-)-Indeloxazine","indeloxazine HCl"],"timeline":[],"approvals":[],"brandName":"(+/-)-Indeloxazine","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your brain is a city with many different streets and intersections. Neurotransmitters are like the traffic signals that help different parts of the brain communicate with each other. Indeloxazine is believed to affect these traffic signals, helping to regulate the flow of information and potentially treating certain conditions.","oneSentence":"Indeloxazine is thought to work by modulating the activity of certain neurotransmitters in the brain.","technicalDetail":"Indeloxazine is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) that modulates the activity of various neurotransmitter systems, including the serotonin, norepinephrine, and dopamine systems."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1435","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=INDELOXAZINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:04:00.352813","biosimilars":[],"competitors":[],"genericName":"indeloxazine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"834M09R1KM","CHEBI":"CHEBI:5894","INN_ID":"5108","RXNORM":"1311672","UMLSCUI":"C0063456","ChEMBL_ID":"CHEMBL2105022","KEGG_DRUG":"D02170","PUBCHEM_CID":"3704","SECONDARY_CAS_RN":"65043-22-3","MESH_SUPPLEMENTAL_RECORD_UI":"C020852"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":58,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"(+/-)-Indeloxazine is a small molecule. It is also known by the synonyms INDELOXAZINA and INDELOXAZINE.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}